PLUS1
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lexaria Bioscience Corporation | LEXX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 2.48 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.48 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.80 - 4.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.48 | USD |
Lexaria Bioscience Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 14.76M | 5.95M | 4.04M | $ 255.40k | $ - | -1.25 | -2.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.50k | 70.30% |
Lexaria Bioscience News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LEXX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.47 | 2.64 | 2.358 | 2.51 | 8,064 | 0.01 | 0.4% |
| 1 Month | 3.07 | 3.5953 | 2.358 | 3.07 | 26,252 | -0.59 | -19.22% |
| 3 Months | 2.55 | 3.5953 | 2.358 | 2.97 | 21,289 | -0.07 | -2.75% |
| 6 Months | 2.48 | 3.5953 | 1.80 | 2.67 | 19,321 | 0.00 | 0.0% |
| 1 Year | 3.15 | 4.83 | 1.80 | 3.67 | 248,457 | -0.67 | -21.27% |
| 3 Years | 4.05 | 12.50 | 1.80 | 5.98 | 419,309 | -1.57 | -38.77% |
| 5 Years | 4.05 | 12.50 | 1.80 | 5.98 | 419,309 | -1.57 | -38.77% |
Lexaria Bioscience Description
| Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. |